X-Ray Reflectivity and Diffraction Studies of Doxorubicin Binding to Model Lipid Membranes

被引:0
作者
Natalia Novikova
Mikhail Kovalchuk
Oleg Konovalov
Nina Stepina
Alexandr Rogachev
Alexey Belov
Olga Maksimenko
Vadim Tarasov
Svetlana Gelperina
Joerg Kreuter
Sergey Yakunin
机构
[1] National Research Centre “Kurchatov Institute”,Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics”
[2] European Synchrotron Radiation Facility,Institute of Pharmaceutical Technology, Biocenter Niederursel
[3] Russian Academy of Sciences,undefined
[4] I.M. Sechenov First Moscow State Medical University (Sechenov University),undefined
[5] D. Mendeleev University of Chemical Technology,undefined
[6] Goethe University,undefined
来源
BioNanoScience | 2020年 / 10卷
关键词
Doxorubicin; Langmuir monolayer; X-ray reflectivity; GID;
D O I
暂无
中图分类号
学科分类号
摘要
The effect of anticancer antibiotic doxorubicin on structural organization of anionic lipid monolayers has been studied. X-ray reflectivity and grazing incidence diffraction techniques were applied to monitor the changes in 2D structure and electron density distribution of Langmuir monolayer composed of negatively charged dipalmitoylphosphatidylglycerol (DPPG) and dioleoylphosphatidylserine (DOPS). For comparison, monolayer of zwitterionic dipalmitoylphosphatidylethanolamine (DPPE) also was investigated. The presented experimental results suggest that doxorubicin interaction with anionic lipid monolayers (DPPG and DOPS) proceeds preferentially via electrostatic attraction—positively charged amino groups of doxorubicin bind to negatively charged head groups of phospholipid molecules. Based on the obtained data, the penetration of doxorubicin into the hydrophobic part of anionic lipid monolayers does not occur. X-ray measurements on DPPE monolayer indicated that doxorubicin did not cause any significant alterations of molecular packing in condensed monolayer of zwitterionic DPPE molecules.
引用
收藏
页码:618 / 624
页数:6
相关论文
共 61 条
[1]  
Tacar O(2013)Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems The Journal of Pharmacy and Pharmacology 65 157-170
[2]  
Sriamornsak P(2011)Doxorubicin pathways: pharmacodynamics and adverse effects Pharmacogenetics and Genomics 21 440-446
[3]  
Dass CR(2017)Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies Scientific Reports 7 1-11
[4]  
Thorn CF(2010)Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids Molecular Pharmaceutics 7 2334-2348
[5]  
Oshiro C(1983)Plasma membrane lipid structural order in doxorubicin-sensitive and-resistant P388 cells Cancer Research 43 5533-5537
[6]  
Marsh S(1994)Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflet of the plasma membrane Biochemistry. 33 13761-13768
[7]  
Hernandez-Boussard T(2011)Structural effects and translocation of doxorubicin in a DPPC/Chol bilayer: the role of cholesterol Biophysical Journal 101 378-385
[8]  
McLeod H(2001)Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers Biochimica et Biophysica Acta - Biomembranes 1514 206-216
[9]  
Klein TE(2017)Daunorubicin and doxorubicin molecular interplay with 2D membrane models Colloids and Surfaces B: Biointerfaces 160 610-618
[10]  
Altman RB(2018)Effect of pH on the interactions of doxorubicin with charged lipid monolayers containing 1, 2-dimyristoyl-sn-glycero-3-phospho-l-serine-an important component of cancer cell membranes Electrochimica Acta 280 229-237